NGM Biopharmaceuticals
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $251M
Investors
- 6
About NGM Biopharmaceuticals
Founded in 2008 and based in California, US, NGM Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing drugs for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. In July 2024, NGM Biopharmaceuticals, Inc. Woodhouse. NGM's Discovery Engine drives the creation of biologic drug candidates. This engine integrates advanced protein and antibody engineering with deep biological expertise to identify and develop therapies for diseases like Primary Sclerosing Cholangitis, Hyperemesis Gravidarum, and various advanced solid tumors. The company's pipeline comprises Aldafermin for Primary Sclerosing Cholangitis, NGM120 for Hyperemesis Gravidarum, NGM707 + pembrolizumab for Advanced Solid Tumors, etc.
Who invested in NGM Biopharmaceuticals
6 investors across 8 rounds
See all investors in NGM Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 17, 2024
Amount
$122M
Investors
Series D
Oct 9, 2014
Amount
$21M
Investors
Series C
May 2, 2013
Amount
$13M
Investors
Series B
Nov 3, 2011
Amount
$17M
Investors
Series B
Mar 15, 2010
Amount
$51M
Investors
Series A
Dec 18, 2009
Amount
$9.6M
Investors
Series A
Feb 24, 2009
Amount
$8.5M
Investors
Series A
Feb 1, 2008
Amount
$8.4M
Investors
Questions about NGM Biopharmaceuticals
Who invested in NGM Biopharmaceuticals?
NGM Biopharmaceuticals has 6 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NGM Biopharmaceuticals raised?
NGM Biopharmaceuticals has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did NGM Biopharmaceuticals last raise money?
NGM Biopharmaceuticals's most recent round on record is a Series A, in Jul 2024.
What does NGM Biopharmaceuticals do?
Founded in 2008 and based in California, US, NGM Biopharmaceuticals, Inc.
Where is NGM Biopharmaceuticals headquartered?
NGM Biopharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like NGM Biopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NGM Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NGM Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.